NEW ORLEANS, March 23, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 4, 2018 to file lead plaintiff applications in a securities class action lawsuit against Atlas Financial Holdings, Inc. (NasdaqGM:AFH), if they purchased the Company’s securities between March 13, 2017, and March 2, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.
Get Help
Atlas investors should visit us at https://www.claimsfiler.com/cases/view-atlas-financial-holdings-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Atlas and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 1, 2018, the Company disclosed that, following “a comprehensive review of its reserves” it was substantially increasing its overall reserves “based on year-end actuarial work coupled with a detailed internal file audit for claims with reserves not established by the Company’s predictive analytics tools….”
On this news, the price of Atlas’ shares plummeted $7.70 per share, over 40%, to close at $11.10 per share on March 2, 2018, on unusually heavy trading volume.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Anta Sports Expands Global Footprint With Strategic Puma Stake
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



